Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01673737 |
| Title | A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Investigational Site Number 840001 | Boston | Massachusetts | 02114 | United States | Details | |
| Investigational Site Number 840101 | Boston | Massachusetts | 02115 | United States | Details | |
| Investigational Site Number 840002 | Houston | Texas | 77054 | United States | Details | |
| Investigational Site Number 124001 | Toronto | M5G 2M9 | Canada | Details |